Chimerix, Inc. , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the extension of its contract with the Biomedical Advanced Research and Development Authority for the continued development of CMX001 as a potential medical countermeasure against smallpox, which is classified as a ... (more)
http://www.drugs.com/clinical_trials/chimerix-barda-continue-collaboration-development-cmx001-15671.html?
http://www.drugs.com/clinical_trials/chimerix-barda-continue-collaboration-development-cmx001-15671.html?
No comments:
Post a Comment